Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM)

Chronic Lymphocytic Leukemia (CLL) is the most prevalent leukemia in Western countries and is notable for its variable clinical course. This variability is partly reflected by the mutational status of IGHV genes. Many CLL samples have been studied in recent years by next-generation sequencing. These...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Rincón, Julia, Garcia-Vela, José A., Gómez, Sagrario, Fernández-Cuevas, Belén, Nova-Gurumeta, Sara, Pérez-Sanz, Nuria, Alcoceba, Miguel, González, Marcos, Anguita, Eduardo, López-Jiménez, Javier, González-Barca, Eva, Yáñez, Lucrecia, Pérez-Persona, Ernesto, de la Serna, Javier, Fernández-Zarzoso, Miguel, Deben, Guillermo, Peñalver, Francisco J., Fernández, María C., de Oteyza, Jaime Pérez, Andreu, M. Ángeles, Ruíz-Guinaldo, M. Ángeles, Paz-Arias, Raquel, García-Malo, M. Dolores, Recasens, Valle, Collado, Rosa, Córdoba, Raúl, Navarro-Matilla, Belén, Sánchez-Beato, Margarita, García-Marco, José A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432772/
https://www.ncbi.nlm.nih.gov/pubmed/34506616
http://dx.doi.org/10.1371/journal.pone.0257353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432772/
https://www.ncbi.nlm.nih.gov/pubmed/34506616
http://dx.doi.org/10.1371/journal.pone.0257353

Ejemplares similares